Injective INJ
Current Price
$3.83 +4.11%
$0.1600 Daily Range (4.18%)
$3.67$3.83
$58.49M Daily Volume
717 BTC
Vol/MktCap: 15.30%
Market Performance
0.15% Relative BTC Volume
The total volume of Injective is $58.49M over the past 24 hours, compared to $39.21B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.77 +1.56%
13 SMA $3.75 +2.12%
21 SMA $3.73 +2.69%
55 SMA $3.74 +2.42%
144 SMA $3.66 +4.73%
Price Performance
+2.17% 1 Hour Change
$3.83 from $3.75
+7.84% 7 Day Change
$0.3001 from $3.53
+18.23% 14 Day Change
$0.6982 from $3.13
+38.37% 30 Day Change
$1.47 from $2.36
All Time High
March 14, 2024
$52.62 -92.73%
-$48.80 vs. now
24H Change
13.41M USD +3.64%
164 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
4.99 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
15.60M INJ
traded over past 24 hours
15.60% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $3.76, showing a 24-hour change of 1.91%, indicating a slight upward momentum. The daily trading range has been relatively tight, with a high of $3.81 and a low of $3.67, suggesting consolidation within this price level.
The trading volume stands at approximately 52.36 million, representing 13.94% of the market cap, which reflects active market participation and interest in the asset. The hourly moving averages indicate a bullish trend, with the 21 SMA at $3.71 showing a gain of 1.40%, reinforcing short-term upward momentum.
The 1-hour Relative Strength Index (RSI) is at 68, nearing overbought territory, while the 7-day RSI is at 55, indicating more room for growth without immediate reversal signals. Price changes over the last 7 days, 14 days, and 30 days are positive at 6.43%, 14.81%, and 35.77%, respectively, demonstrating strong bullish momentum over these periods.
Despite the positive trends, the asset is still significantly below its all-time high of $52.62, indicating substantial room for price appreciation in the long term. The recent price performance supports a bullish outlook, but the high hourly RSI suggests caution in the immediate term to avoid potential short-term corrections.
In conclusion, the current data indicates a favorable trading environment for Injective (INJ). The recommendation is to Buy, as the positive momentum, supportive moving averages, and relatively healthy volume suggest continued upward potential in the near term, despite some caution due to the high RSI.
The trading volume stands at approximately 52.36 million, representing 13.94% of the market cap, which reflects active market participation and interest in the asset. The hourly moving averages indicate a bullish trend, with the 21 SMA at $3.71 showing a gain of 1.40%, reinforcing short-term upward momentum.
The 1-hour Relative Strength Index (RSI) is at 68, nearing overbought territory, while the 7-day RSI is at 55, indicating more room for growth without immediate reversal signals. Price changes over the last 7 days, 14 days, and 30 days are positive at 6.43%, 14.81%, and 35.77%, respectively, demonstrating strong bullish momentum over these periods.
Despite the positive trends, the asset is still significantly below its all-time high of $52.62, indicating substantial room for price appreciation in the long term. The recent price performance supports a bullish outlook, but the high hourly RSI suggests caution in the immediate term to avoid potential short-term corrections.
In conclusion, the current data indicates a favorable trading environment for Injective (INJ). The recommendation is to Buy, as the positive momentum, supportive moving averages, and relatively healthy volume suggest continued upward potential in the near term, despite some caution due to the high RSI.
Updated 186 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Bitcoin ETFs Draw Investment Surge After Brief Lull Threatens Winning Streak
Bitcoin funds are flying high again after a short-lived stretch of outflows nearly wrecked their recent run of green weeks.

Cybercrime Might Be the One Job AI Isn’t Taking, Study Suggests
A Cambridge-led study finds AI is not turning hackers into superhackers.

Ondo Gains Institutional Backing Through DTCC Working Group Selection
Ondo is gaining significant institutional traction after being selected to participate in a key working group led by DTCC.

Trump comments dampen US-Iran diplomatic meeting prospects
Trump's comments may exacerbate US-Iran tensions, potentially hindering diplomatic progress and impacting global oil markets and regional stability.